Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma) - Contacts and Locations

Home

Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma) (Xolair)

This study is ongoing, but not recruiting participants.

Study NCT00367016. Last updated on August 25, 2008. Information provided by University of California, Davis

Please refer to this study by its ClinicalTrials.gov identifier: NCT00367016

Locations


United States, California
	University of California, Davis Department of Dermatology
	Sacramento, California, United States, 95816

Sponsors and Collaborators

University of California, Davis

Investigators


Principal Investigator:	Fu-Tong Liu, M.D.	University of California, Davis